D. WERB ;
E. WOOD ;
T. KERR ;
N. HERSHFIELD ;
R. W. H. PALMER ;
R. S. REMIS
|
2011
Dans International Journal of Drug Policy (Vol.22, n°1, January 2011) Article : Périodique
Dans International Journal of Drug Policy (Vol.22, n°1, January 2011) Article : Périodique
Background Canadian injection drug users (IDUs) are at high risk of hepatitis C virus infection (HCV). However, little is known about the costs associated with their HCV-related medical treatment. We estimated the medical costs of treating HCV-i[...]
Historique